Also, in a recent study performed by Iain Duncan et al., an Australian experience using 99mTc-PSMA SPECT/CT in the primary diagnosis of prostate cancer and staging at biochemical recurrence after local therapy showed that using an enhanced reconstruction algorithm has a diagnostic performance similar to 68Ga-PSMA PET/CT and multiparametric magnetic resonance imaging in an everyday clinical setting [24]. The gene discussed is FOLH1; the disease is prostate carcinoma.